John William Wulf Acquires 45,000 Shares of agilon health, inc. (NYSE:AGL) Stock

agilon health, inc. (NYSE:AGL) Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

agilon health Price Performance

AGL traded down $0.10 during midday trading on Wednesday, reaching $2.00. 3,318,747 shares of the company’s stock were exchanged, compared to its average volume of 4,867,141. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76. The firm has a market capitalization of $821.98 million, a price-to-earnings ratio of -2.23 and a beta of 0.51. The business has a 50-day simple moving average of $2.51 and a two-hundred day simple moving average of $4.46. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the previous year, the business posted ($0.06) earnings per share. As a group, research analysts predict that agilon health, inc. will post -0.5 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AGL. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Sanford C. Bernstein started coverage on agilon health in a research note on Wednesday. They issued a “market perform” rating and a $2.50 price target for the company. Evercore ISI reduced their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. TD Cowen dropped their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research note on Wednesday, October 2nd. Three investment analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $5.02.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently made changes to their positions in the company. J.Safra Asset Management Corp raised its position in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in agilon health in the third quarter worth $28,000. CWM LLC boosted its position in shares of agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC bought a new position in shares of agilon health during the second quarter worth $60,000. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after purchasing an additional 10,674 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.